Welcome to LookChem.com Sign In|Join Free
  • or
C35H39N3O7 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1357569-35-7

Post Buying Request

1357569-35-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1357569-35-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1357569-35-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,7,5,6 and 9 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1357569-35:
(9*1)+(8*3)+(7*5)+(6*7)+(5*5)+(4*6)+(3*9)+(2*3)+(1*5)=197
197 % 10 = 7
So 1357569-35-7 is a valid CAS Registry Number.

1357569-35-7Downstream Products

1357569-35-7Relevant academic research and scientific papers

Synthesis and NMR elucidation of pentacycloundecane-derived hydroxy acid peptides as potential anti-HIV-1 agents

Karpoormath, Rajshekhar,Albericio, Fernando,Govender, Thavendran,Maguire, Glenn E. M.,Kruger, Hendrik G.

, p. 1461 - 1471 (2013/10/22)

The synthesis and NMR elucidation of eight novel peptides incorporating the pentacycloundecane (PCU)-derived hydroxy acid are reported. The PCU cage amino acids were synthesized as racemates and the incorporation of the PCU-derived hydroxy acid with natural (S)-amino acids produced inseparable diastereomeric peptides. A series of overlapping signals from the cage and that of the peptide side chain was observed in the 1H- and 13C-NMR spectra, complicating the elucidation thereof. Two-dimensional NMR techniques proved to be a very useful tool in overcoming these difficulties. These compounds are potential HIV protease inhibitors.

Pentacycloundecane derived hydroxy acid peptides: A new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease inhibitors

Karpoormath, Rajshekhar,Sayed, Yasien,Govender, Patrick,Govender, Thavendran,Kruger, Hendrik G.,Soliman, Mahmoud E.S.,Maguire, Glenn E.M.

experimental part, p. 19 - 29 (2012/03/26)

Novel peptides incorporating the PCU derived hydroxy acid (5-hydroxy-4-oxahexacyclo[5.4.1.02,6.03,10.0 5,9.08,11]dodecane) were synthesized and their activity against the resistance-prone wild type C-South African (C-SA) HIV-protease is reported. The attachment of peptides and peptoids to the PCU derived hydroxy acid resulted in a series of structurally diverse promising HIV-1 protease inhibitors. Amongst the nine novel compounds, 16, 17, 20 and 23 gave IC 50 values ranging from 0.6 to 5.0 μM against the wild type C-SA HIV-1 protease enzyme. Docking studies and molecular dynamic (MD) simulations have been carried out in order to understand the binding mode of the PCU moiety at the active site of the HIV protease enzyme. A conserved hydrogen bonding pattern between the PCU derived hydroxy ether and the active site residues, ASP25/ASP25′, was observed in all active compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1357569-35-7